Effective tobacco control is key to rapid progress in reduction of non-communicable diseases
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tobacco control has been identified as a crucial and necessary part of reaching global non-communicable disease goals, with one in six non-communicable disease-related deaths being attributable to smoking tobacco use.
“Tobacco control has been identified as a crucial and necessary part of reaching these goals, with one in six non-communicable disease-related deaths being attributable to smoking tobacco use.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,271 · see citing works
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60393-0 · Cited by 1,615 · see citing works
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Ward, E., Wu, X., Eheman, C. R., Anderson, R. N., Ajani, U. A., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 946 · see citing works
Tracking global funding for the prevention and control of noncommunicable diseases.
Banerjee, A. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.12.108795 · Cited by 563 · see citing works
Bartenders' respiratory health after establishment of smoke-free bars and taverns.
Eisner, M., Smith, A., & Blanc, P. (1998) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.280.22.1909 · Cited by 398 · see citing works
Framework convention on tobacco controlPossible European linkages
Puska, P., Bettcher, D., & Yach, D. (2000) · European Journal of Public Health · doi:10.1093/eurpub/10.1.5 · Cited by 364 · see citing works
Short-term Economic and Health Benefits of Smoking Cessation: Myocardial Infarction and Stroke
Lightwood, J. M., & Glantz, S. A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1089 · Cited by 347 · see citing works
Self-citationCardiovascular Effect of Bans on Smoking in Public Places
Meyers, D. G., Neuberger, J. S., & He, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.022 · Cited by 346 · see citing works
Fichtenberg, C., & Glantz, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432406 · Cited by 343 · see citing works
Self-citationSmoke-free Legislation and Hospitalizations for Childhood Asthma
Mackay, D., Haw, S. J., Ayres, J. G., Fischbacher, C., & Pell, J. P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002861 · Cited by 303 · see citing works
Efroymson, D., Ahmed, S., Townsend, J. L., Alam, S. M., Dey, A. R., Saha, R., Dhar, B., Sujon, A. I., Ahmed, K. U., & Rahman, O. (2001) · Tobacco Control · doi:10.1136/tc.10.3.212 · Cited by 260 · see citing works
Lightwood, J. M., & Glantz, S. A. (2009) · Circulation · doi:10.1161/circulationaha.109.870691 · Cited by 248 · see citing works
Self-citationSims, M., Maxwell, R., Bauld, L., & Gilmore, A. (2010) · BMJ · doi:10.1136/bmj.c2161 · Cited by 158 · see citing works
Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events
Mackay, D., Irfan, M. M., Haw, S. J., & Pell, J. P. (2010) · Heart · doi:10.1136/hrt.2010.199026 · Cited by 139 · see citing works
Herman, P. M., & Walsh, M. E. (2011) · American Journal of Public Health · doi:10.2105/ajph.2009.179572 · Cited by 136 · see citing works
Naiman, A., Glazier, R. H., & Moineddin, R. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091130 · Cited by 129 · see citing works
John, R. M. (2008) · Social Science & Medicine (1967) · doi:10.1016/j.socscimed.2007.11.020 · Cited by 122 · see citing works
Association of the California Tobacco Control Program with Declines in Lung Cancer Incidence
Barnoya, J., & Glantz, S. (2004) · Cancer Causes and Control · doi:10.1023/b:caco.0000036187.13805.30 · Cited by 118 · see citing works
Self-citationThun, M., & Jemal, A. (2006) · Tobacco Control · doi:10.1136/tc.2006.017749 · Cited by 93 · see citing works
Effect of the California Tobacco Control Program on Personal Health Care Expenditures
Lightwood, J., Dinno, A., & Glantz, S. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050178 · Cited by 83 · see citing works
Self-citationBusch, S. H., Jofre-Bonet, M., Falba, T. A., & Sindelar, J. L. (2004) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200403040-00009 · Cited by 79
Siahpush, M. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.10.798 · Cited by 67 · see citing works
Tobacco spending and children in low income households
Thomson, G., Wilson, N., O'Dea, D., Reid, P., & Howden-Chapman, P. (2002) · Tobacco Control · doi:10.1136/tc.11.4.372 · Cited by 67
Pierce, J., Messer, K., White, M., Kealey, S., & Cowling, D. (2010) · Cancer Epidemiology, Biomarkers and Prevention · doi:10.1158/1055-9965.epi-10-0563 · Cited by 63
Economic evaluation and the postponement of health care costs.
van Baal, P. V., Feenstra, T., Polder, J., Hoogenveen, R., & Brouwer, W. (2011) · Health Economics · doi:10.1002/hec.1599 · Cited by 62 · see citing works
Health and economic implications of a tobacco-free society.
Warner, K. E. (1987) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.1987.03400150072032 · Cited by 55 · see citing works
Pu, C., Lan, V. M., Chou, Y.-J., & Lan, C. (2008) · Social Science & Medicine (1967) · doi:10.1016/j.socscimed.2008.01.007 · Cited by 49
The impact of smoking and quitting on household expenditure patterns and medical care costs in China
Xin, Y., Qian, J., Xu, L., Tang, S., Gao, J., & Critchley, J. (2009) · Tobacco Control · doi:10.1136/tc.2008.026955 · Cited by 46 · see citing works
Ferrante, D., Linetzky, B., Virgolini, M., Schoj, V., & Apelberg, B. J. (2011) · Tobacco Control · doi:10.1136/tc.2010.042325 · Cited by 45 · see citing works
International trade versus public health during the FCTC negotiations, 1999-2003
Mamudu, H. M., Hammond, R., & Glantz, S. A. (2011) · Tobacco Control · doi:10.1136/tc.2009.035352 · Cited by 40 · see citing works
Self-citationEffect of the Arizona Tobacco Control Program on Cigarette Consumption and Healthcare Expenditures
Lightwood, J., & Glantz, S. (2010) · Social Science & Medicine (1967) · doi:10.1016/j.socscimed.2010.11.015 · Cited by 33
Self-citationPutnam, J. (2007) · doi:10.3109/9780203003220-10 · Cited by 17
Mcalister, A., Huang, P., Ramirez, A., Harrist, R., & Fonseca, V. (2010) · American Journal of Public Health · doi:10.2105/ajph.2010.192211 · Cited by 16
Flagged first, then by citations
3 of the 36 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- [6]Institute of Medicine Secondhand smoke exposure and cardiovascular effects: making sense of the evidence 2009 National Academy Press Washington 25032340
- [7]Surgeon General How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease 2010 Public Health Service, Office of the Surgeon General Rockville 21452462
- [25]Rappange DR van Baal PH van Exel NJ Feenstra TL Rutten FF Brouwer WB Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics 2008 26 815 30 18793030
Cited by
Sorted by citations
Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01169-7 · Cited by 1,759 · see citing works
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336 · see citing works
Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies
Mills, E. J., Thorlund, K., Eapen, S., Wu, P., & Prochaska, J. J. (2013) · Circulation · doi:10.1161/circulationaha.113.003961 · Cited by 405 · see citing works
“7 124 Tsai et al 2007(83) Healthy 23(10-60) 21(3-52) 12 6 Varenicline 2 mg/d Counseling 39.”
InfluentialThe vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries
Lee, S., Ling, P. M., & Glantz, S. A. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9914-0 · Cited by 177 · see citing works
“NCDs are now the global development agenda to save millions of lives around the world, particularly in low and middle-income countries.”
BackgroundSelf-citationO'Flaherty, M., Buchan, I., & Capewell, S. (2013) · Heart · doi:10.1136/heartjnl-2012-302300 · Cited by 165 · see citing works
Bajekal, M., Scholes, S., Love, H., Hawkins, N., O'Flaherty, M., Raine, R., & Capewell, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001237 · Cited by 159 · see citing works
Hunter, D. J., & Reddy, K. S. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1109345 · Cited by 522 · see citing works
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease.
van Remoortel, H., Hornikx, M., Langer, D., Burtin, C., Everaerts, S., Verhamme, P., Boonen, S., Gosselink, R., Decramer, M., Troosters, T., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201307-1240oc · Cited by 122 · see citing works
A Comprehensive Lifestyle Peer Group–Based Intervention on Cardiovascular Risk Factors
Gómez-Pardo, E., Fernández-Alvira, J. M., Vilanova, M., Haro, D., Martinez, R. L., Carvajal, I., Carral, V., Rodríguez, C., de Miguel, M., Bodega, P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.033 · Cited by 118 · see citing works
Cochran, S., Bandiera, F., & Mays, V. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301423 · Cited by 83 · see citing works
“001), educational attainment (F [3] = 9.”
BackgroundInfluentialSecond-Hand Tobacco Smoke and Cardiovascular Disease Risk
Dunbar, A., Gotsis, W., & Frishman, W. H. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31827362e4 · Cited by 79 · see citing works
The role of law and governance reform in the global response to non-communicable diseases
Magnusson, R., & Patterson, D. (2014) · Globalization and Health · doi:10.1186/1744-8603-10-44 · Cited by 80 · see citing works
“Countries with high rates of tobacco use cannot hope to make significant progress in reducing NCDs until they make tobacco control a priority [112,113].”
BackgroundRahman, M. S., Rahman, M. M., Gilmour, S., Swe, K. T., Abe, S. K., & Shibuya, K. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30413-8 · Cited by 64 · see citing works
Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
Mathieu, P., Boulanger, M., & Després, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9299-3 · Cited by 56 · see citing works
“Meanwhile, the basic and clinical investigations have shed light on how fat partitioning and the visceral fat contribute to a dysmetabolic state, which promotes CVDs.”
BackgroundInfluentialBurke, H., & Wilkinson, T. M. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0041-2021 · Cited by 53 · see citing works
Basu, S., Glantz, S. A., Bitton, A., & Millett, C. J. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001480 · Cited by 45 · see citing works
“We examined prior rates of expansion in access to these medications; penetration of treatment as primary prevention is below 50% in the UK National Health Service, for example, after over a decade of cardiovascular treatment guideline use [4,26].”
BackgroundSelf-citationSebrié, E. M., Sandoya, E., Hyland, A. J., Bianco, E., Glantz, S. A., & Cummings, K. M. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050134 · Cited by 44 · see citing works
“The implementation of comprehensive smoke-free policies has generally been followed by rapid declines in hospital admissions for AMI, averaging 17% 1 year after the laws took effect and growing to about 30% after 3 years.(8) In fact, our study found a reduction of 22% after 2 years of the implementation of the law.”
BackgroundSelf-citationLencucha, R., Drope, J., Labonté, R., Zulu, R., & Goma, F. (2015) · Tobacco Control · doi:10.1136/tobaccocontrol-2015-052250 · Cited by 46
“job loss/gain, revenue generation, personal choice) perpetuated by the tobacco industry over the years, particularly in tobacco growing countries.(36,37) Studies like this one provide important information to sensitize tobacco control proponents to the perspectives and approaches being fostered outside of the health s…”
BackgroundBiswas, T., Townsend, N. P., Magalhães, R. J. S., Islam, M. S., Hasan, M. M., & Mamun, A. A. (2018) · Current Developments in Nutrition · doi:10.1093/cdn/nzz026 · Cited by 55 · see citing works
“This has grave ramifications for global health, with an increasing prevalence of high BMI likely to lead to increases in noncommunicable diseases (NCDs) (32, 33).”
BackgroundBeen, J. V., Nurmatov, U. B., Cox, B., Nawrot, T. S., van Schayck, O. C. P., & Sheikh, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60082-9 · Cited by 269 · see citing works
Liu, W., Huang, C., Hu, Y., Zou, Z., & Sundell, J. (2013) · Chinese Science Bulletin · doi:10.1007/s11434-013-5728-z · Cited by 36 · see citing works
Golinelli, D., Toscano, F., Bucci, A., Lenzi, J., Fantini, M., Nante, N., & Messina, G. (2017) · Applied Health Economics and Health Policy · doi:10.1007/s40258-017-0342-x · Cited by 38 · see citing works
Psychotic symptoms and smoking in 44 countries
Koyanagi, A., Stickley, A., & Haro, J. M. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12566 · Cited by 37 · see citing works
“In conclusion, given the high prevalence of smoking and psychotic symptoms globally, and the highly damaging effects of smoking on health (32), an increased awareness that psychotic symptoms, regardless of a psychosis diagnosis, are associated with smoking and that among daily smokers, individuals with psychotic sympt…”
BackgroundWhole tobacco smoke extracts to model tobacco dependence in animals
Brennan, K. A., Laugesen, M., & Truman, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.014 · Cited by 36 · see citing works
Global health and cardiovascular disease
Nascimento, B., Brant, L., Moraes, D., & Ribeiro, A. (2014) · Heart · doi:10.1136/heartjnl-2014-306026 · Cited by 34 · see citing works
Cheng, X., & Jin, C. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.779789 · Cited by 28 · see citing works
“First, smoking increases the risk of non-communicable diseases, including cancers and cardiovascular and respiratory diseases (37).”
BackgroundPrenatal second-hand smoke exposure and newborn telomere length
Liu, B., Song, L., Zhang, L., Wu, M., Wang, L., Cao, Z., Xiong, C., Zhang, B., Li, Y., Xia, W., et al. (2019) · Pediatric Research · doi:10.1038/s41390-019-0594-2 · Cited by 37 · see citing works
Disparities in Multiple Chronic Conditions within Populations
Shadmi, E. (2013) · Journal of Comorbidity · doi:10.15256/joc.2013.3.24 · Cited by 32 · see citing works
Jeon, Y., Pyo, J., Park, Y.-K., & Ock, M. (2020) · BMC Public Health · doi:10.1186/s12889-020-09940-7 · Cited by 37 · see citing works
Sui, Q.-H., Liang, J.-Q., Hu, Z.-Y., Chen, Z.-C., Bi, G.-S., Huang, Y.-W., Li, M., Zhan, C., Lin, Z.-W., & Wang, Q. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-276 · Cited by 26 · see citing works
“It is well accepted that tobacco smoking is the primary cause of lung cancer, especially lung squamous cell carcinoma (3-5) since Richard Doll and Austin Bradford Hill first proved the link between smoking and lung cancer in the 1950s (6).”
BackgroundYoung-Wolff, K., Kasza, K., Hyland, A., & McKee, S. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12226 · Cited by 26 · see citing works
Guzman-Castillo, M., Ahmed, R., Hawkins, N., Scholes, S., Wilkinson, E., Lucy, J., Capewell, S., & O'Flaherty, M. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006070 · Cited by 25 · see citing works
Effects of aging on the effectiveness of smoking cessation medication
Scholz, J., Santos, P., Buzo, C. G., Lopes, N., Abe, T., Gaya, P. V., Pierri, H., Amorim, C., & Pereira, A. (2016) · OncoTarget · doi:10.18632/oncotarget.9090 · Cited by 24 · see citing works
“Currently, over 5 million people die from tobacco-related diseases every year, and the number of deaths is estimated to rise to 8 million by 2030 [1-5].”
BackgroundHealth Preemption Behind Closed Doors: Trade Agreements and Fast-Track Authority
Crosbie, E., Gonzalez, M., & Glantz, S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302014 · Cited by 23 · see citing works
Self-citationPuri, P., Singh, S. K., & Pati, S. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053981 · Cited by 29 · see citing works
Zulkiply, S. H., Ramli, L. F., Fisal, Z. A. M., Tabassum, B., & Manaf, R. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242691 · Cited by 22 · see citing works
Dimitrakopoulos, F., Antonacopoulou, A., Kottorou, A., Panagopoulos, N., Kalofonou, F., Sampsonas, F., Scopa, C., Kalofonou, M., Koutras, A., Makatsoris, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50528-y · Cited by 22 · see citing works
Dragomir, A. I., Boucher, V., Bacon, S., Gemme, C., Szczepanik, G., Corace, K., Campbell, T., Vallis, M., Garber, G., Rouleau, C., et al. (2020) · Translational Behavioral Medicine · doi:10.1093/tbm/ibaa015 · Cited by 21 · see citing works
Anti‐tumor effects of miR‐34a by regulating immune cells in the tumor microenvironment
Yin, M., Zhang, Z.-Q., & Wang, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.5826 · Cited by 19 · see citing works
Improved estimation of the health and economic burden of chronic disease risk factors in Manitoba.
Krueger, H., Williams, D., Ready, A., Trenaman, L., & Turner, D. (2013) · Chronic diseases and injuries in Canada · doi:10.24095/hpcdp.33.4.05 · Cited by 19 · see citing works
Blueberry consumption and healthy lifestyles in an emerging market
Muñoz, R. R., Dote-Pardo, J., Henríquez, H. M. G., Araneda‐Flores, J., & Roig, J. M. G. (2019) · Spanish Journal of Agricultural Research · doi:10.5424/sjar/2019174-14195 · Cited by 14 · see citing works
“The literature indicates that smoking is not part of HLS; it is considered as a risk factor for CNCDs and one of the main causes of death worldwide (Glantz & Gonzalez, 2012; WHO, 2015b).”
BackgroundPascale, A., Beal, M. W., & Fitzgerald, T. (2016) · Women s Health Issues · doi:10.1016/j.whi.2015.11.003 · Cited by 14 · see citing works
Walls, H., Liverani, M., Chheng, K., & Parkhurst, J. (2017) · Health Research Policy and Systems · doi:10.1186/s12961-017-0260-2 · Cited by 15 · see citing works
Medical students' tobacco use and attitudes towards tobacco control
Kyung, Y., & Bautista, M. A. (2013) · Medical Education · doi:10.1111/medu.12145 · Cited by 13 · see citing works
Huang, C., Chen, G., Zhang, M., Lu, Y., Hua, Y., Hu, Y., Jin, J., Zhou, J., Bian, Z., Yu, C., et al. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13001 · Cited by 17 · see citing works
“considerable attention in recent years.(20) ETS was classified as a known human pulmonary carcinogen by the International Agency for Research on Cancer.”
BackgroundSchäfer, I., Hansen, H., Kaduszkiewicz, H., Bickel, H., Fuchs, Â., Gensichen, J. S., Maier, W., Riedel-Heller, S. G., König, H., Dahlhaus, A., et al. (2019) · Journal of Comorbidity · doi:10.1177/2235042x19883560 · Cited by 16 · see citing works
Teichert, T., Vossoughi, M., Vierkötter, A., Sugiri, D., Schikowski, T., Hoffmann, B., Schulte, T., Roden, M., Raulf-Heimsoth, M., Luckhaus, C., et al. (2014) · Environmental Research · doi:10.1016/j.envres.2014.06.021 · Cited by 14 · see citing works
Describing and characterising on‐demand delivery of unhealthy commodities in New Zealand
Miles, H., Apeldoorn, B., McKerchar, C., Curl, A., & Crossin, R. (2022) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13230 · Cited by 13
Rey, R., d’Amato, T., Boyer, L., Brunel, L., Aouizerate, B., Berna, F. S., Capdevielle, D., Chéreau, I., Chesnoy-Servanin, G., Denizot, H., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0779-9 · Cited by 26 · see citing works
Web-based survey on smoking cessation behaviors of current and former smokers in Japan
Igarashi, A., Negishi, S., Goto, R., & Suwa, K. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.938149 · Cited by 11 · see citing works
Feliu, A., Anderson, A. S., Bauld, L., Fernández, E., Leitzmann, M. F., Morris, S., Srour, B., Vardavas, C. I., Vlad, I., Vuik, S., et al. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70177 · Cited by 7 · see citing works
“Quitting smoking is the most efficient intervention to reduce the risk of NCDs and improve overall health [118].”
Reviews in environmental health: How systematic are they?
Sutton, P., Chartres, N., Rayasam, S. D. G., Daniels, N., Lam, J., Maghrbi, E., & Woodruff, T. J. (2021) · Environment International · doi:10.1016/j.envint.2021.106473 · Cited by 19 · see citing works
González-Marrón, A., Martín-Sánchez, J., Miró, Q., Matilla-Santander, N., Cartanyà-Hueso, À., Mucci, L., & Martínez-Sánchez, J. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108594 · Cited by 11
Wen, H., Xie, C., Shi, F., Liu, Y., Liu, X.-X., & Yu, C.-H. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1605147 · Cited by 10 · see citing works
Silva, A. P., Issa, J. S., Abe, T. O., Pinheiro, G. G., Gaya, P. V., Pereira, A. C., & Santos, P. C. J. L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0180-4 · Cited by 13 · see citing works
“Background Smoking cessation substantially lowers the risk of death in patients of all ages [1], including those with cardiovascular disease [2].”
BackgroundAl-attas, O., Hussain, T., Al-Daghri, N., Rosas, E. D., Kazmi, U., & Vinodson, B. (2013) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.14837 · Cited by 9 · see citing works
Smoking-attributable burden of lung cancer in the Philippines
Bilano, V. L. F., Borja, M. P., Cruz, E. L., Tan, A. G., Mortera, L. L., & Reganit, P. F. M. (2015) · Tobacco Control · doi:10.1136/tobaccocontrol-2013-051082 · Cited by 7 · see citing works
Cardiovascular Adverse Events Associated with Smoking-Cessation Pharmacotherapies
Sharma, A., Thakar, S., Lavie, C. J., Garg, J., Krishnamoorthy, P. M., Sochor, O., Arbab‐Zadeh, A., & Lichstein, E. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0554-8 · Cited by 4 · see citing works
Wang, Z., Shi, H. C., Peng, L., Zhou, Y., Wang, Y., & Jiang, F. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21767-w · Cited by 9 · see citing works
“Due to the complex ingredients in tobacco smoke, passive and active smoke exposure have been shown to increase the risk and severity of many adverse health outcomes, particularly cancer, cardiovascular, and pulmonary disease (Glantz & Gonzalez 2012, Gram et al.”
BackgroundPathway analysis of smoking-induced changes in buccal mucosal gene expression
Khaleel, A., Alkhawaja, B., Al-Qaisi, T., Alshalabi, L., & Tarkhan, A. H. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00268-y · Cited by 5 · see citing works
“Background Tobacco smoking is responsible for one in six of all deaths from non-communicable diseases, leading experts to identify tobacco control as the highest priority public health intervention [1, 2].”
BackgroundCritical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
Petković, B. B., Kesić, S., & Pešić, V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115094642 · Cited by 4 · see citing works
Burgel, P., & Clini, E. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201311-2029ed · Cited by 4 · see citing works
Testing Club Convergence in Female Smoking Prevalence
Ferretti, F. F., Mariani, M., & Sarti, E. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.875813 · Cited by 5 · see citing works
“Tobacco control is a global public health priority (1).”
BackgroundMethodA COMPARATIVE STUDY OF EFFECTS OF SMOKING ON LIPID PROFILE AMONG HEALTHY SMOKERS AND NON-SMOKERS
Girish, I., & Harish, I. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/141 · Cited by 3 · see citing works
“Smoking is an important modifiable risk factor for various diseases like atherosclerosis, coronary heart diseases, lung & oral cancers, chronic obstructive pulmonary diseases, etc..(5) Around 8–10 lakh people each year in India due to smoking.”
BackgroundBhatt, G., Goel, S., Kiran, T., Grover, S., Medhi, B., Singh, G., & Gill, S. S. (2023) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntad105 · Cited by 4 · see citing works
Passing the “Torches of Freedom”: Smoking Behaviors of Women in Nepal
Piorkowski, K. N., & Bohara, A. (2018) · Feminist Economics · doi:10.1080/13545701.2017.1406192 · Cited by 2 · see citing works
Muckelbauer, R., Englert, H., Rieckmann, N., Chen, C.-M., Wegscheider, K., Völler, H., Katus, H., Willich, S., & Müller-Nordhorn, J. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.05.026 · Cited by 2 · see citing works
Almanah 2014.: globalno zdravlje i kardiovaskularne bolesti
Nascimento, B., Brant, L. H. C., Moraes, D., & Ribeiro, A. (2015) · doi:10.15836/ccar.2015.113 · Cited by 2
Abera, M., Ameya, G., Berhane, M., Grijalva-Eternod, C., Lelijveld, N., Donovan, G. O., Wimborne, E., Anujuo, K., Kirolos, A., Laurentya, O., et al. (2026) · BMJ Global Health · doi:10.1136/bmjgh-2025-021721 · Cited by 1
“Effective preventive strategies include reducing intake of saturated fat, salt, sugar, 53–55 alcohol and nicotine, 56 57 promoting diets rich in fruits, grains, seeds and low-fat animal products, 58 59 and increasing physical activity.”
Kimmie-Dhansay, F., Pontes, C. C., Chikte, U., Erasmus, R., Kengne, A., & Matsha, T. (2021) · South African Dental Journal · doi:10.17159/10.17159/2519-0105/2021/v76no4a5 · Cited by 1 · see citing works
Self-Management Strategies to Curb the Development of NCDs in Rural Communities
Mothiba, T. (2021) · Lifestyle and Epidemiology - Poverty and Cardiovascular Diseases a Double Burden in African Populations [Working Title] · doi:10.5772/intechopen.96222 · Cited by 1 · see citing works
Using Compensating Variation to Measure the Costs of Taxing Cigarette in Iran
Raei, B., Takian, A., Yaseri, M., Abdoli, G., & Emamgholipour, S. (2020) · Health Scope · doi:10.5812/jhealthscope.108121 · Cited by 1 · see citing works
“Tobacco use is extensively acknowledged to be causally linked to suffering communicable and noncommunicable diseases (NCDs) (1, 2).”
BackgroundGhamri, R. (2018) · Journal of Substance Use · doi:10.1080/14659891.2018.1489010 · Cited by 1 · see citing works
“Improved cardiovascular health is among the benefits of smoking cessation (Glantz & Gonzalez, 2012).”
BackgroundThe TAMARA II Trial. Smoking Among Physicians in Argentina
Zylbersztejn, H., Masson, W., Lobo, L., Manente, D., Aurelio, M. J. G., Angel, A., Mulassi, A. H., Giorgi, M., & Rostan, M. (2015) · doi:10.7775/ajc.83.3.5940 · Cited by 1
“(1) Brief interventions during the usual medical consultation by providing counseling to quit smoking are important for controlling and discouraging tobacco use.”
Passive Smoking and Children’s Health
Ciampo, L. A. D., & Ciampo, I. R. L. D. (2014) · Health · doi:10.4236/health.2014.612172 · Cited by 2 · see citing works
Krueger, H., Williams, D., Ready, A., Trenaman, C., & Turner, C. (2013) · doi:10.24095/hpcdp.33.4.05f · Cited by 1
[Smoking cessation in case of chronic kidney disease].
Rostoker, G., Faou, A. L., & Lagrue, G. (2013) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2012.10.008 · Cited by 1 · see citing works
“[8] Glantz S, Gonzalez M.”
BackgroundSmoke-Free Air: An Important Strategy to Reduce Heart Attacks
Tan, C. E., & Glantz, S. A. (2012) · Global Heart · doi:10.1016/j.gheart.2012.03.002 · Cited by 1 · see citing works
“[1] While it is widely accepted that tobacco is responsible for a significant disease burden and that reducing tobacco use will reduce these diseases,[2] it is less well-appreciated that reducing exposure to secondhand tobacco smoke produces large and rapid reductions in heart disease-related events, including hospita…”
Self-citationShin, J., Park, E.-C., Bae, H.-C., Hong, S., Jang, S., Kim, J.-H., Chang, J.-S., & Lee, S. G. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.1.109 · Cited by 1
“In fact, population-based efforts to lower tobacco use, mainly cigarettes, have reduced the lung cancer rates (Bamoya and Glantz, 2004; Thun and Jemal, 2006; Jemal et al., 2008; Glantz and Gonzalez, 2012).”
BackgroundCigarette pack labelling practices in Nigeria-Implications for policy recommendations -
Abayomi, O. (2013) · doi:10.5455/jbh.20130919043326 · Cited by 1
“Tobacco control policies have been associated with reducing rates of non-communicable diseases [13].”
BackgroundAdvocacy Strategies to Address NCDs: Tobacco Control
Sparks, M. W. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7594-1_19 · Cited by 1 · see citing works
Husnain, M. I. U., Hajizadeh, M., Ahmad, H., & Khanam, R. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01798-8 · Cited by 1 · see citing works
“Second, smoking is associated with risk of many diseases including cardiovascular and cancer [178], which results in worse HRQoL [179].”
Taye, B. (2025) · medRxiv · doi:10.1101/2025.09.23.25336463
“Concomitant harm reduction treatment in anti-HCV treatment settings provides additional opportunities to prevent chronic diseases including diseases of the liver, cardiovascular system, and the kidney(Fan et al., 2015; Glantz & Gonzalez, 2012).”
Sushma, B. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i3s.2862
“Oxidative stress and lipid profile alterations are key mechanisms underlying this association [1,2,3,4].”
Dsk, D., Mdub, G., Lhanm, L., Rdbg, M., Ranasinghe, D., Rajasuriya, M., Mahesh, B., & Psmab, P. (2018) · COJ Technical & Scientific Research · doi:10.31031/cojts.2018.02.000506
“A recent systematic review concluded that the cessation of tobacco smoking has significantly reduced the progression of atherosclerotic disease and improved the respiratory function among those who were affected with chronic respiratory diseases [17].”
BackgroundAnil, S. (2016) · doi:10.1201/9781315368511-13
NCI's state and community research initiative: a model for future tobacco control research
Roeseler, A. G., Meaney, M., Riordan, M., Solomon, M., Herndon, S., & Hallett, C. (2016) · Tobacco Control · doi:10.1136/tobaccocontrol-2016-053350
Girvalaki, C., Lazuras, L., Tzortzi, A., Triantafylli, D., & Lionis, C. (2015) · doi:10.18332/tpc/61168
“…NCDs it is important to maintain effective tobacco control policies and eliminate the tobacco industry practices that potentially undermine them 2, 3 Tobacco industry advertising in Greece was rampant prior to the adoption of a nationwide outdoor advertising ban in 2009, which led to the…”
Passive smoking: a reluctance to simplicity
Editorial office of Asian Biomedicine (2012) · doi:10.5372/1905-7415.0605.103
“This process will enable us to continually refine decision making to reap the greatest benefits from effective tobacco control, which is key to rapid progress in reduction of non-communicable diseases [9, 11].”
Background
- Authors
- Glantz, S., & Gonzalez, M.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Glantz, Stanton
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 379
- Issue
- 9822
- Pages
- 1269-1271
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3260384
- OpenAlex
- W2106545070
- Cited by
- 99
- References
- 36
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 7 · 2015: 8 · 2014: 12 · 2013: 13 · 2012: 10
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA-113710 and CA-61021)
- University of California Tobacco-Related Disease Research Program (20FT-0077)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Health Sciences › Health Professions › General Health Professions › Public Health Policies and Education
- Keywords
- tobacco control, non-communicable diseases, tobacco use, alcohol policy, minimum unit pricing, cardiovascular disease, chronic respiratory disease, cancer, diabetes mellitus, public health policy, low- and middle-income countries
- MeSH terms
- Smoking Prevention, Cardiovascular Diseases, Cause of Death, Chronic Disease, Cross-Cultural Comparison, Diabetes Mellitus, Type 2, Health Plan Implementation, Humans, Neoplasms, Risk Factors, Smoking, Socioeconomic Factors, Tobacco Smoke Pollution, United Nations, World Health Organization, Smoking Cessation, Tobacco Industry, Tobacco Use Cessation, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
